Syncope: Investigation and treatment

被引:2
作者
Raj S.R. [1 ]
Sheldon R.S. [1 ]
机构
[1] Faculty of Medicine, University of Calgary, Health Sciences Centre, NW, Calgary, AB, T2N 4N1
基金
加拿大健康研究院;
关键词
Structural Heart Disease; Midodrine; Vasovagal Syncope; Tilt Table Test; Unexplained Syncope;
D O I
10.1007/s11886-002-0035-3
中图分类号
学科分类号
摘要
Syncope is a common condition that can be both disabling and expensive to treat. Although investigative modalities are sometimes required, a diagnosis can often be made with a good history and physical exam. Recent reports have identified specific historic features that are more suggestive of cardiac syncope as compared with vasovagal syncope and seizures. Advances in ambulatory electrocardiography (in particular the implantable loop recorder) have proven invaluable in both difficult-to-diagnose syncope, and in advancing our knowledge of its mechanisms. When clear dysrhythmias are manifest, appropriate therapies are self-evident. However, recurrent vasovagal syncope continues to be a condition that can be difficult to treat. Fortunately, there are well-conducted trials of both pharmacologic therapies (b-blockers, alpha agonists, and selective serotonin reuptake inhibitors) and nonpharmacologic treatments (orthostatic physical training and dual-chamber pacemakers) that should provide more guidance in the near future. © 2002 by Current Science Inc.
引用
收藏
页码:363 / 370
页数:7
相关论文
共 66 条
[61]  
Sutton R., Brignole M., Menozzi C., Et al., Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope: Pacemaker versus no therapy: A multicenter randomized study. The vasovagal syncope international study (vasis) investigators, Circulation, 102, pp. 294-299, (2000)
[62]  
Ammirati F., Colivicchi F., Santini M., Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope : A multicenter, randomized, controlled trial, Circulation, 104, pp. 52-57, (2001)
[63]  
Raviele A., Giada F., Sutton R., Et al., The vasovagal syncope and pacing (synpace) trial: Rationale and study design, Europace, 3, pp. 336-341, (2001)
[64]  
Brennan F.J., Mitchell L.B., Sheldon R.S., Et al., Assessment of the cardiac patient for fitness to drive: 1996 update, Can J Cardiol, 12, pp. 1164-1170, (1996)
[65]  
Epstein A.E., Miles W.M., Benditt D.G., Et al., Personal and public safety issues related to arrhythmias that may affect consciousness: Implications for regulation and physician recommendations. A medical/scientific statement from the american heart association and the north american society of pacing and electrophysiology, Circulation, 94, pp. 1147-1166, (1996)
[66]  
Petch M.C., Driving and heart disease, Eur Heart J, 19, pp. 1165-1177, (1998)